PGIMER extends last date of thesis, protocol submission for MDS course; Details

Published On 2020-07-12 03:30 GMT   |   Update On 2020-07-12 03:30 GMT
Advertisement

Chandigarh: Through a recent notification, the Post Graduate Institute of Medical Education and Research, Chandigarh (PGIMER) has informed about the extension of the last date of thesis and protocol submission which was due in June 2020.

This is for the information of all the Junior Residents enrolled in January 2018 and July 2019 sessions for MDS course at PGIMER, Chandigarh that the competent authority is pleased to approve the extension of the last date of thesis and protocol submission due in June 2020 upto 30th September 2020. Please note that no further extension after 30.09.2020 shall be granted.

Advertisement

This has been issued with the approval of the Director, PGIMER, Chandigarh.

Candidates are advised to keep checking the website i.e. www.pgimer.edu.in regularly for any further updates.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News